0000-0002-1419-8607 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (278)
- Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients Save
- What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment? Save
- Risk stratification of patients with TP53-mutated myeloproliferative neoplasms. Save
- A Stem and Progenitor Cell-Derived Gene Expression Signature is Prognostic for Survival in Myelofibrosis. Save
- Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis. Save
- Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus Save
- Final safety and efficacy results from a phase 1/2 study of tagraxofusp, a CD123-targeted therapy, for myelofibrosis Save
- Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study Save
- Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia. Save
- ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis. Save